TREATMENT WITH CERTOLIZUMAB PEGOL IN RA - DATA FROM THE NATIONAL REGISTRY ARTIS (ANTIRHEUMATIC THERAPIES IN SWEDEN)

被引：0
|
作者：
Chatzidionysiou, K. [1 ]
van Vollenhoven, R. [1 ]
机构：
[1] Karolinska Inst, Clintrid, Dept Rheumatol, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.3084
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：517 / 518
页数：2
相关论文
共 50 条
  • [21] Adherence Rates with Certolizumab Pegol Therapy: Results from a Retrospective Analysis of Patient Claims Data
    Wolf, Douglas
    Jaganathan, Srihari
    Burudpakdee, Chakkarin
    Seetasith, Arpamas
    Gucky, Jay
    Low, Robert
    Schwartz, David
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S26 - S26
  • [22] One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national US rheumatoid arthritis registry
    Harrold, Leslie R.
    Litman, Heather J.
    Saunders, Katherine C.
    Dandreo, Kimberly J.
    Gershenson, Bernice
    Greenberg, Jeffrey D.
    Low, Robert
    Stark, Jeffrey
    Suruki, Robert
    Jaganathan, Srihari
    Kremer, Joel M.
    Yassine, Mohamed
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [23] Oral cladribine in the treatment of multiple sclerosis - data from the national registry ReMuS® registry
    Horakova, D.
    Vachova, M.
    Tvaroh, A.
    Drahota, J.
    Mazouchova, A.
    Mares, J.
    Woznicova, I.
    Zimova, D.
    Libertinova, J.
    Martinkova, A.
    Recmanova, E.
    Grunermelova, M.
    Valis, M.
    Adamkova, J.
    Ampapa, R.
    Benesova, Y.
    Dufek, M.
    Peterka, M.
    Havrdova, E. Kubala
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2021, 84 (06) : 555 - 561
  • [24] Associations Between Disease Activity, Physical Function and Antirheumatic Medications With All-Cause Mortality in Rheumatoid Arthritis (RA): Data From a Canadian RA Registry
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Kuriya, Bindee
    Aydin, Sibel
    Keystone, Edward
    Pope, Janet
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2024, 51 : 14 - 15
  • [25] Radiographic progression in RA patients treated with infliximab, data from the Czech National Registry (attra)
    Pavelka, K
    Vencovsky, J
    Tegzova, D
    Gatterova, J
    Dusek, L
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 263 - 263
  • [26] THERAPY WITH CERTOLIZUMAB PEGOL AND OTHER TNF-A INHIBITORS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE CORRONA REGISTRY
    Pappas, D. A.
    Etzel, C. J.
    Bedenbaugh, A.
    Tambiah, J.
    Greenberg, J. D.
    VALUE IN HEALTH, 2014, 17 (03) : A43 - A43
  • [27] A Faster Clinical Response to Certolizumab Pegol (CZP) Treatment is Associated With Better 52-Week Outcomes in Patients With Rheumatoid Arthritis (RA)
    Keystone, Edward
    Curtis, Jeffrey
    Fleisehmann, Roy
    Mease, Philip
    Khanna, Dinesh
    Smolen, Joseph
    Coteur, G.
    Combe, Bernard
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1333 - 1334
  • [28] Predictors of Response and Remission to Certolizumab Pegol in Patients With Crohn's Disease: Data From the WELCOME Study
    Sandborn, William J.
    Abreu, Maria T.
    D'Haens, Geert R.
    Colombel, Jean-Frederic
    Vermeire, Severine
    Mitchev, Krassimir
    Ernault, Etienne
    Fedorak, Richard N.
    Spehlmann, Martina
    Wolf, Douglas C.
    Lee, Scott D.
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2010, 138 (05) : S164 - S164
  • [29] DMARD Withdrawal in RA Patients Achieving Therapeutic Response with Certolizumab Pegol Combined with Dmards: Results from a Canadian Randomized Study
    Pope, Janet E.
    Rampakakis, Emmanouil
    Vaillancourt, Julie
    Grant, Eric
    Bessette, Louis
    Lazovskis, Juris
    Haraoui, Boulos
    Sampalis, John S.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] A FASTER CLINICAL RESPONSE TO CERTOLIZUMAB PEGOL (CZP) TREATMENT IS ASSOCIATED WITH BETTER 52-WEEK OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Keystone, Edward
    Curtis, Jeffery
    Fleischmann, Roy
    Mease, Philip
    Khanna, Dinesh
    Smolen, Josef
    Coteur, Geoffroy
    Combe, Bernard
    RHEUMATOLOGY, 2010, 49 : I102 - I102
12345